Mohan Naidu analyst

Currently out of the existing stock ratings of Mohan Naidu, 67 are a BUY (95.71%), 3 are a HOLD (4.29%).

Mohan Naidu

Work Performance Price Targets & Ratings Chart

Analyst Mohan Naidu, employed carries an average stock price target met ratio of 77.42% that have a potential upside of 31.21% achieved within 499 days on average.

Mohan Naidu’s has documented 149 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on TDOC, Teladoc at 25-Oct-2023.

Wall Street Analyst Mohan Naidu

Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for OMCL (OMNICELL) at 10/26/2018. The price target of $73 was fulfilled within 12 days with a profit of $8.5 (13.18%) receiving and performance score of 10.98.

Average potential price target upside

HQY HealthEquity OMCL Omnicell TDOC Teladoc TVTY Tivity Health VCRA Vocera Communications ATHN athenahealth CERN Cerner Corp CVS CVS Health Corp HMSY HMS Holdings Corp EVH Evolent Health PINC Premier TRHC Tabula Rasa HealthCare

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

100

$17.52 (21.24%)

85

12 days ago

1/3 (33.33%)

$15.16 (17.87%)

630

Buy

105

$22.52 (27.30%)

70

13 days ago

9/10 (90%)

$21.6 (25.90%)

86

Buy

105

$22.52 (27.30%)

85

13 days ago

14/16 (87.5%)

$21.6 (25.90%)

115

Buy

104

$21.52 (26.09%)

92

13 days ago

9/12 (75%)

$20.6 (24.70%)

63

Buy

92

$9.52 (11.54%)

90

13 days ago

7/10 (70%)

$8.6 (10.31%)

131

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Mohan Naidu?

On 2015

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?